Lexicon Pharmaceuticals (LXRX) Revenue & Revenue Breakdown
Lexicon Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$49.80M
Latest Revenue (Q)
$14.18M
Main Segment (Y)
License
Lexicon Pharmaceuticals Revenue by Period
Lexicon Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $49.80M | 60.24% |
| 2024-12-31 | $31.08M | 2481.48% |
| 2023-12-31 | $1.20M | 766.19% |
| 2022-12-31 | $139.00K | -53.36% |
| 2021-12-31 | $298.00K | -98.76% |
| 2020-12-31 | $24.00M | -92.55% |
| 2019-12-31 | $322.07M | 409.54% |
| 2018-12-31 | $63.21M | -30.03% |
| 2017-12-31 | $90.33M | 8.40% |
| 2016-12-31 | $83.34M | -35.90% |
| 2015-12-31 | $130.01M | 468.89% |
| 2014-12-31 | $22.85M | 928.53% |
| 2013-12-31 | $2.22M | 104.04% |
| 2012-12-31 | $1.09M | -41.10% |
| 2011-12-31 | $1.85M | -62.33% |
| 2010-12-31 | $4.91M | -54.13% |
| 2009-12-31 | $10.70M | -66.89% |
| 2008-12-31 | $32.32M | -35.51% |
| 2007-12-31 | $50.12M | -31.15% |
| 2006-12-31 | $72.80M | -3.81% |
| 2005-12-31 | $75.68M | 22.58% |
| 2004-12-31 | $61.74M | 44.12% |
| 2003-12-31 | $42.84M | 21.70% |
| 2002-12-31 | $35.20M | -88.48% |
| 2001-12-31 | $305.58M | 2013.47% |
| 2000-12-31 | $14.46M | 207.63% |
| 1999-12-31 | $4.70M | - |
Lexicon Pharmaceuticals generated $49.80M in revenue during NA 2025, up 60.24% compared to the previous quarter, and up 207.56% compared to the same period a year ago.
Lexicon Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $14.18M | -50.87% |
| 2025-06-30 | $28.87M | 2187.32% |
| 2025-03-31 | $1.26M | -95.25% |
| 2024-12-31 | $26.55M | 1417.37% |
| 2024-09-30 | $1.75M | 6.25% |
| 2024-06-30 | $1.65M | 45.75% |
| 2024-03-31 | $1.13M | 60.97% |
| 2023-12-31 | $702.00K | 333.33% |
| 2023-09-30 | $162.00K | -48.90% |
| 2023-06-30 | $317.00K | 1220.83% |
| 2023-03-31 | $24.00K | -14.29% |
| 2022-12-31 | $28.00K | -28.21% |
| 2022-09-30 | $39.00K | 11.43% |
| 2022-06-30 | $35.00K | -5.41% |
| 2022-03-31 | $37.00K | 164.29% |
| 2021-12-31 | $14.00K | -39.13% |
| 2021-09-30 | $23.00K | -90.17% |
| 2021-06-30 | $234.00K | 766.67% |
| 2021-03-31 | $27.00K | -86.43% |
| 2020-12-31 | $199.00K | -97.00% |
| 2020-09-30 | $6.63M | -27.60% |
| 2020-06-30 | $9.16M | 14.55% |
| 2020-03-31 | $8.00M | -8.34% |
| 2019-12-31 | $8.73M | -97.04% |
| 2019-09-30 | $294.45M | 2941.19% |
| 2019-06-30 | $9.68M | 5.06% |
| 2019-03-31 | $9.22M | -46.01% |
| 2018-12-31 | $17.07M | 148.99% |
| 2018-09-30 | $6.86M | -50.15% |
| 2018-06-30 | $13.75M | -45.44% |
| 2018-03-31 | $25.21M | -23.72% |
| 2017-12-31 | $33.05M | 22.66% |
| 2017-09-30 | $26.94M | 123.53% |
| 2017-06-30 | $12.05M | -34.11% |
| 2017-03-31 | $18.29M | -20.59% |
| 2016-12-31 | $23.04M | -16.88% |
| 2016-09-30 | $27.72M | 37.97% |
| 2016-06-30 | $20.09M | 60.79% |
| 2016-03-31 | $12.49M | -90.18% |
| 2015-12-31 | $127.28M | 22387.63% |
| 2015-09-30 | $566.00K | 50.53% |
| 2015-06-30 | $376.00K | -79.02% |
| 2015-03-31 | $1.79M | -91.66% |
| 2014-12-31 | $21.48M | 5026.97% |
| 2014-09-30 | $419.00K | -38.02% |
| 2014-06-30 | $676.00K | 144.04% |
| 2014-03-31 | $277.00K | -80.35% |
| 2013-12-31 | $1.41M | 492.44% |
| 2013-09-30 | $238.00K | 11.21% |
| 2013-06-30 | $214.00K | -40.56% |
| 2013-03-31 | $360.00K | 65.14% |
| 2012-12-31 | $218.00K | -41.40% |
| 2012-09-30 | $372.00K | 86.93% |
| 2012-06-30 | $199.00K | -33.67% |
| 2012-03-31 | $300.00K | -12.54% |
| 2011-12-31 | $343.00K | -3.38% |
| 2011-09-30 | $355.00K | -36.04% |
| 2011-06-30 | $555.00K | -6.88% |
| 2011-03-31 | $596.00K | -52.43% |
| 2010-12-31 | $1.25M | 60.44% |
| 2010-09-30 | $781.00K | -36.66% |
| 2010-06-30 | $1.23M | -24.86% |
| 2010-03-31 | $1.64M | 16.22% |
| 2009-12-31 | $1.41M | -33.74% |
| 2009-09-30 | $2.13M | -28.71% |
| 2009-06-30 | $2.99M | -28.29% |
| 2009-03-31 | $4.17M | -34.36% |
| 2008-12-31 | $6.35M | -15.47% |
| 2008-09-30 | $7.51M | -21.47% |
| 2008-06-30 | $9.57M | 7.57% |
| 2008-03-31 | $8.89M | -35.60% |
| 2007-12-31 | $13.81M | - |
Lexicon Pharmaceuticals generated $14.18M in revenue during Q3 2025, up -50.87% compared to the previous quarter, and up 861.08% compared to the same period a year ago.
Lexicon Pharmaceuticals Revenue Breakdown
Lexicon Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 |
|---|---|---|
| License | $45.00M | - |
| Product | $4.65M | - |
| Reportable Segment | - | $31.08M |
Latest
Lexicon Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 25: License (90.64%), and Product (9.36%).
Quarterly Revenue by Product
| Product/Service | Dec 25 | Sep 25 | Jun 25 | Mar 25 |
|---|---|---|---|---|
| Product | $2.32M | $1.01M | $1.32M | - |
| License | $4.26M | $13.20M | $27.54M | $45.00 |
Latest
Lexicon Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: License (64.75%), and Product (35.25%).
Lexicon Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| GOSS | Gossamer Bio | $114.70M | $13.29M |
| ADCT | ADC Therapeutics | $73.55M | $15.75M |
| LXRX | Lexicon Pharmaceuticals | $49.80M | $14.18M |
| BCYC | Bicycle Therapeutics | $35.27M | $11.73M |
| OCGN | Ocugen | $4.41M | $1.75M |
| RAPT | RAPT Therapeutics | - | - |
| CMPX | Compass Therapeutics | - | - |
| FULC | Fulcrum Therapeutics | - | - |
| FDMT | 4D Molecular Therapeutics | - | - |
| NMRA | Neumora Therapeutics | - | - |
| OMER | Omeros | - | - |